Fundraising FoxViroCarb
2 known investors
Find your way into ViroCarb
Sign up to see every warm intro you have to ViroCarb
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ViroCarb team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ViroCarb is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its leadership brings experience in early-stage biopharma, medical devices, and industrial R&D.
Founders & leadership
BT
Bharat TewarieCEO & Chairman of the Board
MH
Mario HuescaPresident, COO & Board DirectorDr. Huesca co-founded ViroCarb, a biotechnology company developing antiviral therapies, and brings over 20 years of experience in drug discovery for cancer and infectious diseases. He holds a Ph.D. in molecular and medical genetics from the University of Toronto and postdoctoral training in microbiology, followed by work as a scientist and senior R&D manager in small molecule development.
CL
Clifford LingwoodCSO & Board DirectorClifford Lingwood is Chief Scientific Officer and Board Director of ViroCarb, a biopharmaceutical company developing small molecule therapeutics for viral infections. He previously founded ERAD Therapeutics and has expertise in glycosphingolipid biochemistry and biosynthesis.
Board
DM
Daniel MamelakBoard Director
ML
Michael LingBoard Director
Investors · 2
Frequently asked questions
- What does ViroCarb do?
- ViroCarb is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its leadership brings experience in early-stage biopharma, medical devices, and industrial R&D.
- Who are ViroCarb's investors?
- ViroCarb's investors include Beresford Ventures, Innovation UBC.